CLEARWATER, FL – April 20, 2016 – Bovie Medical Corporation, a maker of medical devices and supplies, and the developer of J-Plasma®, a patented new surgical product, today announced the launch of its J-Plasma® product extension, branded the Precise 360.

This new J-Plasma® hand piece has an angled and rotating tip that enables surgeons access to structures that are difficult to reach using a straight laparoscopic device.

One of the first surgeons to use the Precise 360 is Vipul Patel, MD, a world-renowned urologist and leader in robotic surgery and a member of Bovie’s Medical Advisory Board. Dr. Patel is the head of the Global Robotics Institute at Florida Hospital in Orlando and has personally performed over 9,000 robotic prostatectomies.

Commenting on Precise 360, Dr. Patel said, “By inserting the new angle tip of the Precise 360™ in the ancillary port of the DaVinci robot, the surgeon gains greater access, control and precision than the straight stick versions. With this level of precision, control and safety, J-Plasma has the potential to become a standard of care in a range of procedures.”

J-Plasma®, Bovie’s transformational surgical product, enables surgeons to operate with greater precision on and around delicate structures with minimal thermal spread. The Precise 360 extension builds on last year’s additions to the J-Plasma® portfolio, which includedblade and needle configurations in three different instrument lengths.

“We continue to innovate J-Plasma® to address specific procedures for which it is particularly well-suited,” said Robert L. Gershon, Chief Executive Officer. “The next J-Plasma® portfolio additions will include a configuration specifically designed for use in robotic surgery, developed in close collaboration with Bovie’s Medical Advisory Board, which in addition to Dr. Patel, is comprised of two prominent robotic surgeons in the fields of cardiovascular and cardiothoracic surgery.”

About Bovie Medical Corporation

Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented new plasma-based surgical product for cutting and coagulation. J-Plasma® utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. Bovie Medical Corporation is also a leader in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the Company’s own well-respected brands (Bovie®, Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie Medical Corporation’s website

Investor Relations:
MBS Value Partners
Hugh Collins
(212) 223-4632